Tel: 561-316-3330
Email: mdnewsmagazine@infomeddnews.com
Home Blog Page 22

Transform Your Sleep: Health Benefits of Upgrading to a Bed-in-a-Box Mattress

Bed-in-a-Box Mattress

Mattresses in a box have become very popular lately. There are thousands of stories about it on social media, and it’s all over the web. Why are these mattresses called “beds in a box? ”

Here are a few benefits of purchasing a box bed that we discuss in this article.

The decision to purchase a mattress is an important one, and when researching your options, you want to be sure you’re buying a good one. The first thing you should know about beds in boxes is exactly what they are. Check out Top Bed-in-a-Box Mattress Options as well.

What is a Bed in a Box?

The simplest definition of a bed in a box is something that is shipped to you after being ordered online. Rolls and compressed foam mattresses are usually used.

Following that, it is packed into a box and shipped straight to you. Moving is often made easier with the right-sized box.

It only takes a few minutes for the mattress to expand once you have unpacked it, laid it flat, and waited for it to expand. Eventually, the shape will return to its original state. After knowing what a bed in a box is, let’s look at its benefits.

Reduced costs

Beds in a box are usually less expensive than traditional mattresses because they eliminate manual labor.

Beds in a box can cost thousands, but most of these mattresses are more affordable than standard mattresses. Almost every month of the year, you’ll find online sales.

Direct-to-consumer sales reduce overhead costs so that manufacturers can pass savings on to customers.

Fast delivery and easy setup

You will not be charged any delivery fees since your bed in a box will be shipped directly to you. It also saves you the trouble of figuring out how to get your new mattress home. It’s definitely not a good idea to strap a bed to the roof of your car.

Compressed mattresses are delivered right to your door. There is a manageable size box included. Consequently, you don’t have to lug a large, cumbersome mattress through doorways or upstairs.

It takes no time at all to set up the system once you arrive at home.

In just a few minutes, you can open the box, lay out your mattress, and it fluffs back up again. Once the compressed mattress has been positioned on your box spring or bed frame, it simply needs to be inflated. It usually takes about a day to complete this process.

Next, it’s off to bed for a dreamy night’s rest.

Realistic Options

There are a lot of mattress choices, which can be frustrating when shopping for a mattress. It can be even more challenging because of that.

The good news is that there are fewer options available when you purchase a bed in a box. By doing this, you will be able to choose the perfect one for you.

An online bed retailer may offer a handful of different mattresses, rather than 20 from a traditional mattress store. There is no better way to choose than this.

Conclusion

Having learned about the benefits of bed in a box mattresses, it’s time to buy one. However, make sure you do your research. It’s important that you consider what’s important to you when you have options. Comfort and cost are two of the most important factors for many.

As well as considering your body type and sleep position, consider how much support you need. Check the mattress’ features, like cooling technology, motion isolation, and removable, washable covers, as you do your research.

It provides superior comfort and support thanks to its hybrid memory foam construction.

Pro Power Save Reviews Canada: Is It the Ultimate #Energy Saver?

As energy costs continue to rise, consumers are constantly on the lookout for ways to reduce their monthly bills. Pro Power Save promises to be a solution that can help households cut down on energy consumption. But how effective is it really? In this article, we will delve into Pro Power Save reviews, exploring its features, benefits, and potential drawbacks.

In today’s world, where energy costs are rising and environmental concerns are becoming increasingly important, energy-saving devices have gained popularity among consumers. Among these devices, the Pro Power Save has emerged as a promising solution for reducing electricity bills and promoting a more sustainable lifestyle. But how effective is it really? In this detailed review, we will delve into the features, benefits, and potential drawbacks of the Pro Power Save device, providing you with an in-depth understanding of whether it truly lives up to the hype.

What is Pro Power Save?

Pro Power Save is a compact, plug-in device that claims to optimize the energy usage of household appliances. By stabilizing the electrical current and reducing energy wastage, it promises to lower your electricity bills. But how does it work, and is it worth the investment?

The Pro Power Save is an energy-saving device designed to optimize the power consumption in households and businesses. It claims to reduce energy wastage, stabilize voltage, and improve the overall efficiency of electrical appliances. By doing so, it promises significant reductions in electricity bills, making it an attractive option for those looking to cut down on their energy expenses.

Por Power Save Review – ALERT! My Honest Experience- 2024!

How Does Pro Power Save Work?

The device operates by reducing power surges and spikes, ensuring that your appliances run more efficiently. It also claims to prevent energy from being wasted as heat, which is a common issue in many households. Simply plug the device into any socket, and it begins working immediately, optimizing the energy flow throughout your home.

The Pro Power Save device operates on a simple yet effective principle. It is equipped with advanced technology that filters and stabilizes the electrical current flowing into your home. This process, known as power factor correction, ensures that your electrical appliances use power more efficiently, reducing the amount of energy wasted in the form of heat and electromagnetic radiation.

When plugged into a standard electrical outlet, the Pro Power Save continuously monitors and optimizes the electrical flow, leading to a more stable and efficient power supply. By minimizing power surges and reducing the overall load on your electrical system, the device helps in extending the lifespan of your appliances and lowering your electricity consumption.

Visit the product’s official website for more information.

Benefits of Using Pro Power Save

  1. Lower Energy Bills: The most significant advantage of using Pro Power Save is the potential reduction in your electricity bills. By improving energy efficiency, it helps you save money every month.
  2. Easy Installation: Pro Power Save is incredibly easy to install. Just plug it in, and it starts working. There’s no need for professional installation or complicated setup processes.
  3. Environmental Impact: Reducing energy consumption not only saves money but also benefits the environment. By using less electricity, you’re reducing your carbon footprint and contributing to a more sustainable future.
  4. Long-Term Savings: While the initial cost of the device may seem like an investment, the long-term savings on your energy bills can quickly outweigh this expense.

Last opportunity Last days to get this GREAT offer

Significant Reduction in Electricity Bills

One of the primary benefits of using the Pro Power Save is the potential for significant reductions in electricity bills. By optimizing the power consumption of your appliances and reducing energy wastage, the device can lead to noticeable savings on your monthly utility bills. Over time, these savings can add up to a substantial amount, making the Pro Power Save a valuable investment for budget-conscious consumers.

Prolonged Lifespan of Electrical Appliances

The Pro Power Save helps in prolonging the lifespan of your electrical appliances by stabilizing voltage and reducing power surges. Voltage fluctuations and power surges are common causes of damage to electrical devices, leading to costly repairs or replacements. By ensuring a stable power supply, the Pro Power Save minimizes wear and tear on your appliances, helping them to last longer and perform more efficiently.

Environmentally Friendly

In addition to its cost-saving benefits, the Pro Power Save is also an environmentally friendly solution. By reducing energy wastage and optimizing power consumption, the device contributes to a lower carbon footprint. This makes it an ideal choice for consumers who are conscious of their environmental impact and want to take steps towards a more sustainable lifestyle.

Easy to Use and Maintain

The Pro Power Save is designed for ease of use, with a simple plug-and-play installation process. Once installed, the device requires minimal maintenance, making it a hassle-free addition to your home or business. Its user-friendly design ensures that you can start enjoying the benefits of energy savings with minimal effort.

Last opportunity Last days to get this GREAT offer

Key Features of Pro Power Save

  1. Voltage Stabilization

One of the standout features of the Pro Power Save is its ability to stabilize voltage fluctuations. Voltage instability is a common issue in many households, often leading to inefficiencies in power consumption and potential damage to electrical appliances. The Pro Power Save addresses this problem by ensuring a consistent and stable voltage supply, which not only protects your devices but also optimizes their performance.

  1. Energy Monitoring

The Pro Power Save is equipped with an energy monitoring system that provides real-time data on your power consumption. This feature allows users to track their energy usage patterns and make informed decisions on how to further reduce their electricity bills. By identifying the most energy-intensive appliances, users can take steps to minimize their usage or replace them with more energy-efficient alternatives.

  1. Easy Installation

Installing the Pro Power Save is a straightforward process that does not require any technical expertise. The device is designed to be plug-and-play, meaning you simply need to plug it into a standard electrical outlet, and it will start working immediately. This ease of use makes it accessible to a wide range of consumers, regardless of their technical know-how.

  1. Safety Features

Safety is a crucial consideration when using any electrical device, and the Pro Power Save does not disappoint in this regard. The device is built with high-quality materials and incorporates safety features such as surge protection and overheating prevention. These features ensure that the Pro Power Save operates safely and reliably, even in the most demanding environments.

  1. Cost-Effective Solution

With rising electricity costs, the Pro Power Save offers a cost-effective solution for homeowners and businesses looking to reduce their energy expenses. By optimizing power consumption and minimizing wastage, the device can lead to substantial savings on electricity bills over time. The initial investment in the Pro Power Save is relatively low compared to the potential savings, making it a worthwhile consideration for anyone looking to cut down on energy costs.

Drawbacks and Considerations

  1. Effectiveness: While many users report significant savings, some reviews suggest that the effectiveness of Pro Power Save can vary depending on the home and appliances. It’s essential to manage expectations and understand that results may differ.
  2. Upfront Cost: Although the device promises long-term savings, the upfront cost may be a consideration for some consumers. However, this cost is often offset by the potential savings on energy bills.
  3. Dependence on Usage: The savings achieved with Pro Power Save can depend on the number of devices and appliances in use. Households with high energy consumption are likely to see more significant savings.
  1. Effectiveness May Vary The effectiveness of the Pro Power Save may vary depending on factors such as the size of your home, the quality of your electrical system, and your overall energy consumption. In some cases, the device may not deliver the same level of savings as advertised, particularly in homes with newer, more efficient electrical systems.
  2. Limited Impact on Large Appliances While the Pro Power Save can optimize the power consumption of smaller appliances and electronics, its impact on larger, high-energy appliances such as refrigerators and air conditioners may be limited. These appliances typically have their own built-in power management systems, which may reduce the effectiveness of the Pro Power Save.
  3. Requires Consistent Use To achieve the best results, the Pro Power Save needs to be plugged in and used consistently. If the device is unplugged or not used regularly, its ability to deliver energy savings will be diminished. Consumers should be aware of this requirement and ensure that the device is continuously in use to maximize its benefits.

Pro Power Save Review

>>> Click Here To Visit – “OFFICIAL WEBSITE” <<<

Customer Reviews and Feedback

Pro Power Save has received mixed reviews from users. Many customers praise the device for its ease of use and noticeable reduction in energy bills. However, others have expressed concerns about the device’s overall effectiveness, particularly in homes with lower energy consumption. It’s always a good idea to read multiple reviews and gather as much information as possible before making a purchase.

Is Pro Power Save Worth It?

Pro Power Save offers a promising solution for those looking to reduce their energy bills. While it may not be a one-size-fits-all solution, its potential benefits make it worth considering, especially for households with high energy consumption. As with any product, it’s essential to weigh the pros and cons and consider how it fits your specific needs.

Conclusion: Is Pro Power Save Worth It?

The Pro Power Save offers a compelling solution for those looking to reduce their electricity bills and promote a more sustainable lifestyle. With features such as voltage stabilization, energy monitoring, and easy installation, the device provides a convenient and cost-effective way to optimize power consumption in your home or business.

However, it is important to manage your expectations and understand that the effectiveness of the Pro Power Save may vary based on individual circumstances. While it can deliver significant savings for some users, others may experience more modest results. Overall, the Pro Power Save is a valuable tool for energy-conscious consumers, but it may not be the ultimate solution for everyone.

In conclusion, Pro Power Save is a device that could help you lower your energy bills and reduce your environmental impact. With its easy installation and potential for long-term savings, it’s an option worth exploring. However, it’s important to manage your expectations and understand that results may vary.

Would you like to try Pro Power Save in your home? If so, it’s crucial to purchase from a reputable source and consider your household’s energy needs.

 

 

 

Engineering Better Healthcare: The Vital Role of Usability Testing and HFE/UE in Medical Device Development | By Oliver Eikenberg

Usability Testing and HFE/UE

As the MedTech markets expand globally, the need for user-centered design has never been greater. According to the FDA, human factors engineering (HFE) and usability engineering (UE) focus on studying how people interact with technology and how user interface design impacts medical device interactions.

Both HFE and UE are based on the international usability standards IEC 62366-1 and IEC 62366-2 with consideration of risk management (ISO 14971). By planning and integrating usability testing for human interaction with medical device technology throughout the device lifecycle and risk management processes, HFE/UE ensures that medical devices meet the complex needs of healthcare professionals and patients, and that user-related and use-related risks are eliminated or mitigated.

Consequently, usability and HFE processes play a pivotal role in ensuring medical devices are safe, effective, and user-friendly. Only by identifying and integrating relevant human factors early in the design process can medical device engineers make informed design decisions regarding ergonomics, materials, and labeling.

The importance of usability and HFE in medical device design

Usability and Human Factors Engineering (HFE) in healthcare is not a recent requirement, but its importance has grown alongside technological innovations and the increasing complexity of interactions and use scenarios of medical devices, which can be more error-prone without meticulous design. An early empirical example of the effectiveness of usability and HFE in healthcare was seen in the redesign of a patient-controlled analgesia (PCA) pump’s user interface (Lin et al., 1998). The study showed reduced programming time, decreased mental workload, and fewer errors, highlighting the practical benefits of HFE in medical equipment design.

Usability and HFE considerations encompass three primary components: device users (e.g., nurse, professional caregiver, etc.), device use environments (hospital, home, etc.), and device user interfaces (visual displays, alarms, etc.). The concept of user-centered design is a strategic approach to design development that aims to place the end-user at the center of the design process and simulate real-life use scenarios to effectively identify usability issues.

Ultimately, the overall usability goal is to prioritize designing systems around people’s tasks and work, thereby minimizing human errors. To achieve this, manufacturers must first perform one or more formative usability evaluations (exploratory studies) of the reasonably foreseeable hazard-related use scenarios to explore and understand user interface design strengths, weaknesses, needs, pain points, and unanticipated use errors. Engaging with potential users such as healthcare professionals and patients can provide valuable insights for design decisions. Formative usability evaluations should be conducted during the development phases (concept generation phase) and are understood as development-accompanying evaluations of the user-product interface. At the end of design development (design validation), summative usability testing must be conducted to demonstrate that the device is safe for use by its intended users. Such summative usability testing should involve the intended users under realistic conditions and may be combined with clinical testing. This proactive approach to formative and summative usability testing (human factors studies) diminishes the necessity for extensive redesigns, thereby enhancing the probability of successful design development. By doing so, it saves valuable time and resources while optimizing human performance, ensuring that medical devices operate safely and effectively in their intended use environments. It is crucial that usability evaluations are conducted by teams that include engineers, designers, HFE specialists, and clinical experts. This multidisciplinary approach ensures feedback from all involved parties and integrates these diverse perspectives into the design and risk management processes.

However, usability does not stop after design development; it applies throughout the entire product development process and may include post-market evaluations for identifying design flaws or confirming adequate usability for design changes.

Balancing common usability elements and regulatory requirements

While the fundamental usability goals of improving safety and effectiveness are widely harmonized, regulatory bodies in various regions may emphasize specific usability or HFE guidelines or have unique interpretations and priorities. For example, China’s NMPA guidelines now align with the US-FDA recommended minimum of 15 users per group. Additionally, the approach and methods align with those recommended by the FDA and in IEC 62366-1 in the US and EU. However, testing in China mandates the use of Chinese for instructions and labeling, whereas English suffices in the US, and national member state languages (>20) are required in most countries of the EU. Therefore, depending on the users (specifically for lay users) and use scenarios, planning for multilingual testing may become essential during summative evaluations, not only to develop safe-to-use devices but also to meet basic regulatory requirements.

Regulatory submissions in the US, EU, the UK, and China necessitate formative usability evaluations and summative usability testing with a specified number of users in the intended use environments. This testing must be conducted with the final product design as part of the design validation. If not planned and carried out methodically throughout the design phases, the process of planning, selecting appropriate users (participants), testing, and providing comprehensive analysis and feedback into design as well as risk management documents can be time-consuming and expensive. Quite often, during reviews from authorities or Notified Bodies, documentation for usability is found to be inadequate, resulting in a non-conformity being raised, which often consequently requires re-testing or halting marketing. Therefore, manufacturers should carefully pay attention to these fundamental usability requirements to ensure regulatory compliance and ease of market success. Manufacturers aiming to sell across multiple regions and potential region-specific differences are recommended to familiarize themselves with relevant HFE standards and guidelines and to integrate these requirements early in the design process before starting usability testing.

Conclusion

Medical devices should be designed and developed to be safe and effective. The implementation and use of an adequate usability or HFE process is not only a reasonable way to make design development and risk management more efficient, but it is also a regulatory requirement for medical device manufacturers in most regions, and is increasingly reviewed during submissions by regulatory bodies. Regulators worldwide have harmonized the requirements for usability and use or refer to the international standard IEC 62366-1. This standard provides excellent guidance on how to implement formative and summative usability testing in the design development process. To confirm regulatory compliance in these markets, additional HFE guidelines that are specific to certain regions must also be followed. This is significant because these standards and guidelines are frequently the only basis for interpretation and expectations from regulators and reviewers. It might be acceptable for manufacturers to employ alternative techniques if they do not adhere to them closely enough, but doing so could also lead to serious concerns during regulator reviews. A thorough understanding and proper application of usability and HFE, along with their integration with risk management, are crucial for the entire design team in medical device companies. These elements form the foundation for developing safe and effective medical devices efficiently.

Editor’s note:  Oliver Eikenberg brings over 14 years of extensive experience in the medical device industry, covering R&D, manufacturing, QC, and product management, alongside 15 years in regulatory and quality affairs consulting. His expertise spans EU, US, and Australian regulations. Oliver has specialized expertise in IVD genetic tests, Companion Diagnostics, in-house tests (LDTs) and clinical performance studies and interaction with Notified Bodies and Competent Authorities. 

Jupiter Endovascular Exits Stealth With $21M in New Financing to Fund Pivotal Trial for Pulmonary Embolism

Jupiter Endovascular, Inc., a medical technology startup developing a new class of endovascular procedures using Endoportal ControlTM to bring the precision and control of direct surgical access to catheter-based interventions, announced today that it has exited stealth mode with a $21 million new round of financing. Sonder Capital was a key participant in the round that included participation from multiple strategic investors. The funding will be used to support the company’s upcoming pivotal trial for Pulmonary Embolism and development of additional clinical applications of the Endoportal ControlTM technology.

“For decades, the field of catheter-based therapies has been limited by the technological constraints of catheters that lose stability and control within the anatomy,” said Kate Garrett, Managing Partner at Sonder Capital. “Jupiter Endovascular has developed a revolutionary approach with the potential to overcome these constraints by providing clinicians the precision and control of a surgical approach while maintaining the minimally invasive profile of an endovascular procedure. This novel approach may address a significant unmet clinical need in patients with disease residing in complex cardiovascular anatomies, such as the pulmonary arteries.”

The company has appointed Carl J. St. Bernard as Jupiter Endovascular’s Chief Executive Officer. St. Bernard, an industry veteran with a wealth of medical technology leadership experience, joins Jupiter from Alta Biomaterials, where he held the role of President and CEO. He has over 30 years of experience in the life sciences arena and has held senior executive positions at CeloNova BioSciences, Tryton Medical, Johnson & Johnson Vision, LifeCell, Cordis, and GE Healthcare. He is also an AdvaMed board director.

“I am very excited to join the Jupiter Endovascular team. The Endoportal ControlTM technology, which leverages Jupiter’s unique and exclusive intellectual property to create a catheter-based device that flexibly navigates through a patient’s vasculature before fixing into a stable position, is designed to give interventionalists the confidence and support they need to deliver a prescribed cardiovascular therapy. This represents a generational advance in technology with the potential to revolutionize the treatment of millions of patients worldwide,” said St. Bernard. “We are thrilled to partner with Sonder Capital and our other highly valued investors as we bring this innovation to the clinic and create the foundation for our entry into the Pulmonary Embolism market and future clinical areas where we see a compelling opportunity for Endoportal ControlTM to improve the lives and well-being of patients.”

“We are excited to welcome Carl St. Bernard as the CEO of Jupiter Endovascular,” said Jay Watkins, Co-Chair and Partner at Sonder Capital. “Carl brings a wealth of experience and a proven track record of success in bringing novel technologies and therapies to market. His vision and leadership will be instrumental as the Jupiter team enters this next clinical phase. We are confident that, under Carl’s guidance, Jupiter Endovascular will address a significant clinical need that has remained unmet for decades.”

restor3d Expands Healthcare Innovation | Welcomes New Robotics and Navigation Experts

restor3d
restor3d's Larry Hazbun, Senior Vice President of Robotics and Kirstin Widding, Senior Vice President of Hip & Knee

restor3d, the medical technology leader in 3D printed, personalized orthopedic implants, announced its strategic expansion into the field of robotics and navigation through the appointment of seasoned leaders, Larry Hazbun and Kirstin Widding.

restor3d is at the forefront of innovation in the field of personalized orthopedic solutions, utilizing advanced 3D printing technology to create patient-specific implants that match the natural human anatomy and provide optimal osseointegration. The company is expanding its capabilities into the realm of robotics and navigation for the surgical delivery of patient specific implants. This expansion aligns with restor3d’s mission to improve patient care through cutting-edge implant technology and also positions the company to offer a suite of tools in the future that allow surgeons to perform patient specific implant procedures using their preferred method of enabling technology.

“We welcome the addition of Larry Hazbun, Senior Vice President of Robotics and Kirstin Widding, Senior Vice President of Hip & Knee.” Said Ken Gall, restor3d Chief Commercial Officer and Co-Founder. “The addition of robotics and navigation technologies is a natural fit with personalization and a perfect compliment to our patient specific implants. By integrating these enabling technologies with our existing 3D-printed patient specific implants and instruments, restor3d is poised to offer a more holistic approach to personalized patient treatment.”

Larry is a forward-thinking executive with over 25 years in leadership of research and development across automotive, aerospace, and medical industries. Before joining restor3d, Larry was the VP of Product Development for the Imaging, Navigation, and Robotics business unit at Globus Medical focusing on navigated and robotic spine surgery. Prior to that, Larry held multiple leadership roles at Mako Surgical Corp, which later went on to be acquired by Stryker, and was instrumental in the development of the Mako robotic assisted surgical platform for total knee, hip, and other orthopedic applications.

Kirstin brings extensive experience as a strategic commercial leader in total hip, knee, shoulder, and enabling technologies with a proven track record of driving revenue growth through impactful integrated marketing, communications, branding, and product solutions. With an unparalleled focus on customer satisfaction, she has successfully developed commercialization strategies, strengthened corporate brands, and built strong relationships with surgeons and distributor partners. Her expertise in business development, strategic partnerships, and product portfolio management, combined with a commitment to innovation and collaboration, positions her as a key change agent within the industry.

With the strategic expansion into robotics and navigation, coupled with the leadership of Larry Hazbun and Kirstin Widding, restor3d is well-positioned to continue its trajectory of innovation in the orthopedic industry. The company remains committed to pushing the boundaries of personalized healthcare, delivering solutions that include both patient specific implants and a multitude of personalized surgical delivery systems. As restor3d continues to integrate these enabling technologies, it reaffirms its dedication to transforming the future of orthopedic surgery and enhancing patient outcomes worldwide.

SoWell Launches The First and Only Supplement System for GLP-1 Users to Thrive on the Medication

SoWell
SoWell

SoWell announced the launch of the only three-part supplement system designed specifically for GLP-1 users and their side effects: the SoWell GLP-1 Support System ($104.99). Dr. Alexandra Sowa, MD, board-certified obesity medicine specialist, and forthcoming author of ‘The Ozempic Revolution’ (HarperCollins, Winter 2025), developed this product from a decade of GLP-1 research and patient care to specifically meet the unique needs of individuals on a GLP-1 weight loss journey. Despite 50% of GLP-1 users experiencing side effects, individuals are left to navigate an overwhelming assortment of supplements that are not specifically formulated to their body’s new sensitivities or needs.

Currently, 1 in 8 Americans are using Ozempic or similar GLP-1 drugs, yet over 70% of users stop taking these life-changing medications within one year largely because of side effects they find too hard to navigate. This three-part supplement system is based on the latest clinical research and the founder’s decade-long experience working with GLP-1 patients. The SoWell GLP-1 Support System is formulated to target the unique side effects and requirements of GLP-1 users, providing comprehensive support to ensure a sustained and simplified journey on GLP-1 drugs. The product can be sold as a bundle of all three stick pack supplements, retailing for ($104.99) or available individually for flexibility: SoWell Electrolytes ($34.99), SoWell Protein ($44.99), and SoWell Fiber ($34.99).

The SoWell GLP-1 Support System extends far beyond an electrolyte, protein, and fiber supplement, combining 17 evidence-based ingredients that alleviate side effects like nausea, constipation, diarrhea, fatigue, headaches, muscle loss, weakened skin elasticity, and hair loss, all in easy-to-use stick packs. Each formulation in the protocol is enhanced with targeted ingredients to make the line more gut-friendly than alternatives and developed for the unique taste buds of GLP-1 users, who are more sensitive to overly sweet and artificial flavors. The entire system is low sugar, low carbohydrate, and free of artificial flavors, colorings, or sweeteners.

“As a physician specializing in internal and obesity medicine, I have spent over a decade working with GLP-1 patients and understanding their unique needs and challenges,” explains Dr. Alexandra Sowa, Founder of SoWell. “But other products on the market didn’t meet my standards and weren’t developed for GLP-1 users. There is a critical gap in the market when it comes to addressing the side effects and specific requirements of GLP-1 users on their weight loss journey. The SoWell GLP-1 Support System is designed to support and enhance the effectiveness of GLP-1 therapies while helping users achieve their health goals more comfortably and effectively.”

Dr. Sowa’s deep understanding of GLP-1 medications has enabled her patients to avoid the typical side effects of GLP-1 treatments. This insight drove the creation of the GLP-1 Support System, aiming to assist even more GLP-1 users throughout every step of their journey.

SoWell GLP-1 Support System Product Details:

Full GLP-1 Support System ($104.99): Includes the SoWell Electrolytes, SoWell Protein, and SoWell Fiber.

  • SoWell Electrolytes ($34.99): This daily electrolyte formula helps GLP-1 users maintain healthy hydration levels while simultaneously addressing nausea and fatigue with targeted ingredients like vitamin B6 and trace minerals. Since GLP-1 users can be sensitive to artificial and overly sweet flavors, this blend features a light, natural flavor with 0g sugar and 1g carb.
  • SoWell Protein ($44.99): By combining 25g whey isolate and collagen protein with digestive enzymes, this low-carb protein powder helps GLP-1 users maintain muscle mass, skin elasticity, and hair density as they lose weight without the digestive upset that other protein powders can cause.
  • SoWell Fiber ($34.99): GLP-1 medications slow the digestive process, which can lead to constipation and diarrhea. This triple-action blend of psyllium husk, guar gum, and apple pectin fiber works quickly to balance digestion while promoting long-term gut health. Enhanced with magnesium glycinate and 7.5 billion CFU probiotics, this one-of-a-kind formula gives GLP-1 users the gut support they need with 0g sugar and 1g net carb per serving.

For more information about SoWell or to order your first GLP-1 Support System, please visit here.

Hoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer Therapeutic

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced that it has entered into a Master Services Agreement with Aronnax, Inc. for its HT-KIT cancer therapeutic.

HT-KIT research, which was conducted at NC State University to evaluate the efficacy of HT-KIT in cancerous and non-cancerous cells, has demonstrated that HT-KIT effectively kills human mast cells that rely on signaling through the KIT receptor to survive. The effect of a single dose lasted for about two weeks, while reduced KIT expression lasted for 7 days. This result also demonstrated HT-KIT’s potential to reduce KIT expression using GIST cells and kill within 48 and 72 hours along with lower KIT expression in AML cells over 72 hours.

HT-KIT is an antisense oligonucleotide that targets the proto-oncogene cKIT being developed for the treatment of mast cell-derived cancers and anaphylaxis and previously received Orphan Drug Designation from FDA.

Aronnax will oversee the third-party provider, ITR Laboratories, conducting intravenous injection using increasing/decreasing doses for each subsequent group. A timeframe of forty-eight hours will be allowed between each dose group. This study will provide Hoth key metrics in both max dose and range finding elements which will help formulate its proposed clinical trial.

“We continue to make quick progress in moving HT-KIT from the lab to patients. This further analysis will help us with that process, finalizing the protocols in our upcoming IND-enabling study,” stated Robb Knie, Chief Executive Officer. “We are pleased to further engage Aronnax and ITR Laboratories on these key studies given their reputation for IND-enabling studies.”

MolecuLight Secures $11.7 Million in Financing to Accelerate Global Expansion

MolecuLight Inc., a leader in point-of-care fluorescence imaging, today announced the closing of a $11.7 million Series C financing round led by new investors Export Development Canada (EDC), Prosegur, and Azahar. Existing investors also participated in the round, demonstrating continued confidence in the company’s growth trajectory.

MolecuLight’s fluorescence imaging devices provide clinicians with real-time visualization of bacteria florescence in wounds, enabling earlier detection and quantification leading to more effective treatment resulting in improved wound healing. MolecuLight’s wound bed assessment aligns perfectly with CTP outcomes: A study by Ai-Jalodi and colleagues demonstrates that when the device indicates a bacteria-free wound bed, there is a 100% probability of CTP integration1,  vs a skin substitute alone.

By empowering healthcare providers to make informed decisions at the point of care, MolecuLight is helping to improve patient outcomes and reduce healthcare costs. The new investment will fuel MolecuLight’s expansion in the US, Canada, and EU across all care settings, including hospital out-patient, independent wound care clinics, podiatrists, and long-term care centers. This growth will enable the company to reach more patients and positively impact their lives by providing clinicians with the tools to quickly and accurately identify and quantify bacteria that impair wound healing, in turn improving patient outcomes.

“MolecuLight’s innovative technology has the potential to significantly improve patient outcomes and offers compelling benefits for all healthcare system stakeholders,” said Guillermo Freire, Senior Vice-President, Mid-Market Group, EDC. “We are excited to invest in MolecuLight as they accelerate commercialization. EDC is focused on supporting emerging Canadian innovators in critical sectors essential for the future. This investment reflects our belief in innovation and progress, underscoring mission is to support Canadian companies in their journey to become international leaders in their sectors.”

“We are pleased to invest in MolecuLight. We believe in MolecuLight’s mission to transform wound care and with their innovative technology,” said Pedro Munoz, General Manager at Azahar. “This investment will enable MolecuLight to accelerate its expansion efforts to more healthcare providers worldwide.”

“iGan is proud to continue supporting MolecuLight on their journey to transform the management of wound care,” said Sam Ifergan, Chairman of MolecuLight and Managing Director at iGan Partners.

“This financing is a testament to MolecuLight’s strong market position and the significant impact our technology is having on patient care,” said Anil Amlani, CEO of MolecuLight. “With the support of our investors, we are well-positioned to capitalize on the growing demand for point-of-care fluorescence imaging solutions and deliver exceptional value to our customers.”

Tungsten Advisors served as the exclusive financial advisor to MolecuLight.

____________________________

1 Ai-Jalodi O, Sabo M, Patel K, Bullock N, Serena L, Breisinger K, Serena TE. Efficacy and safety of a porcine peritoneum-derived matrix in diabetic foot ulcer treatment: a pilot study. J Wound Care. 2021 Feb 1;30(Sup2):S18-S23. doi: 10.12968/jowc.2021.30.Sup2.S18. PMID: 33573495.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, today announced the full market release of its VASCADE MVP® XL mid-bore venous closure system.

The VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics’ VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.

The VASCADE MVP XL system utilizes 58% more collagen and a larger disc than the VASCADE MVP® system, providing a robust closure solution for procedures requiring 10-12F sheaths (up to 15F in outer diameter) such as cryoablation or Pulsed Field Ablation (PFA) procedures and Left Atrial Appendage Closure (LAAC). VASCADE MVP XL has been available in a limited market release as of June 2024, and since then has been used by approximately 80 physicians at more than 30 hospitals, across multiple types of procedures.

“We received overwhelmingly positive feedback during our limited market release and we are excited to make VASCADE MVP XL available to physicians at all U.S. hospitals as soon as possible,” said Stew Strong, President, Global Hospital at Haemonetics. “With our full market release underway and an ongoing clinical trial program to broaden the indications for this device to even larger access points, VASCADE MVP XL will complement our Interventional Technologies portfolio, and underscore our aspiration to be the go-to leader in vascular closure.”

Haemonetics’ current VASCADE portfolio also includes the VASCADE system, designed for “small-bore” femoral arterial and venous closure with standard 5-6/7F procedural sheaths, and the VASCADE MVP system, designed for “mid-bore” multi-access femoral venous closure with 6-12F ID procedural sheaths.

osteolabs Publishes First Real-World Evidence Data from Close to 3, 000 OsteoTest Patient Samples

osteolabs GmbH, an innovative diagnostic company applying its proprietary CIM (Calcium isotope marker) technology for the early detection of Calcium-related metabolic bone diseases affecting over 1 billion patients worldwide, announced today the publication of real-world evidence data from close to 3,000 OsteoTest patient samples in the prestigious journal Bone.

The publication, accessible online (DOI: https://doi.org/10.1016/j.bone.2024.117210) marks the first report on the real-world application of CIM in the serum and urine of 2,960 patient samples in total. This study was conducted in collaboration with renowned colleagues at GEOMAR (Helmholtz-Center for Ocean Research Kiel, Germany), the University Hospital Schleswig-Holstein (UKSH, Kiel, Germany), and the UCL Great Ormond Street Hospital (London, United Kingdom). The data demonstrate a strong correlation between CIM and various metabolic diseases affecting musculoskeletal metabolism. Furthermore, the results align in full accordance with earlier clinical validation data and the established CIM threshold values for Bone Calcium Balance (BCaB).(1)

“We are very excited about the results from this collaborative effort that have now culminated in a publication in Bone, “ said Prof. Anton Eisenhauer who is a key inventor of the CIM technology and osteolabs´ Chief Scientific Officer. “This larger subset of routine clinical samples fully supports the potential for OsteoTest to qualify as a new universal diagnostic method for early osteoporosis risk assessment and therapeutic control.”

1...212223...923Page 22 of 923

About us

Medical Device News Magazine

Welcome to Medical Device News Magazine, a digital publication providing up to the minute medical device news and biotechnology news.

Need to know more?

Contact us

Navigation

Florida, New York
United States
Phone Number: 1.561.316.3330